DTB Select: Patiromer plus spironolactone in resistant hypertension and CKD

Summary and context are provided for an RCT (n=295) in people with resistant hypertension and chronic kidney disease which found that more people in the patiromer arm could continue taking spironolactone vs the placebo arm (owing to less hyperkalaemia).


Drug and Therapeutics Bulletin